Skip to main content
Premium Trial:

Request an Annual Quote

Dan Calvo, George Dunbar

Accuri Cytometers this week announced the appointment of Dan Calvo and George Dunbar to newly created positions on its board of directors.
Dunbar is currently president, CEO, and a director of Aastrom Biosciences, a company specializing in autologous stem cell products for use in regenerative medicine.
Prior to Aastrom,  Dunbar served as CEO of several life science companies including Quantum Dot Corporation, Targesome, Epic Therapeutics, Cytotherapeutics, Stem Cells, and Metra Biosystems. Earlier in his career, Dunbar held management positions with the Ares-Serono Group and Amersham International.

Calvo is currently president and CEO of Assay Designs, which provides research assays and reagents to biomedical, pharmaceutical, and translational research companies. Prior to Assay Designs, Calvo was CEO of Cellomics. Previously, Calvo held positions with PerkinElmer Life and Analytical Sciences, NEN Life Sciences, and DuPont.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.